A closer look at DIASORIN Valuation | 34D.BE - Macroaxis

DIASORIN Valuation

34D Stock  EUR 100.30  0.85  0.84%   
At this time, the firm appears to be fairly valued. DIASORIN owns a latest Real Value of €102.53 per share. The recent price of the firm is €100.3. Our model computes the value of DIASORIN from analyzing the firm fundamentals such as Price To Book of 4.51 X, net income of 310.97 M, and EBITDA of 517.3 M as well as examining its technical indicators and probability of bankruptcy.
Fairly Valued
Today
100.30
100.3100.3102.5102.53100.3100.3
Please note that DIASORIN's price fluctuation is very steady at this time. Calculation of the real value of DIASORIN is based on 3 months time horizon. Increasing DIASORIN's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the DIASORIN stock is determined by what a typical buyer is willing to pay for full or partial control of DIASORIN. Since DIASORIN is currently traded on the exchange, buyers and sellers on that exchange determine the market value of DIASORIN Stock. However, DIASORIN's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value.
Historical Market  100.3 Real  102.53 Hype  100.3
The real value of DIASORIN Stock, also known as its intrinsic value, is the underlying worth of DIASORIN Company, which is reflected in its stock price. It is based on DIASORIN's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of DIASORIN's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
102.53
Real Value
104.02
Upside
Estimating the potential upside or downside of DIASORIN helps investors to forecast how DIASORIN stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of DIASORIN more accurately as focusing exclusively on DIASORIN's fundamentals will not take into account other important factors:
Hype
Prediction
LowEstimatedHigh
98.81100.30101.79
Details

DIASORIN Total Value Analysis

DIASORIN is presently forecasted to have takeover price of 8.21 B with market capitalization of 9.85 B, debt of 1.23 B, and cash on hands of . Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the DIASORIN fundamentals before making investing decisions based on enterprise value of the company

DIASORIN Asset Utilization

The concept of asset utilization usually refers to the revenue earned for every dollar of assets a company currently reports. The latest return on assets of DIASORIN indicates not a very effective usage of assets in December.

DIASORIN Profitability Analysis

The company reported the revenue of 1.24 B. Net Income was 310.97 M with profit before overhead, payroll, taxes, and interest of 0.
Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates DIASORIN's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in DIASORIN and how it compares across the competition.

About DIASORIN Valuation

The stock valuation mechanism determines DIASORIN's current worth on a weekly basis. Our valuation model uses a comparative analysis of DIASORIN. We calculate exposure to DIASORIN's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of DIASORIN's related companies.

8 Steps to conduct DIASORIN's Valuation Analysis

Company's valuation is the process of determining the worth of any company in monetary terms. It estimates DIASORIN's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct DIASORIN's valuation analysis, follow these 8 steps:
  • Gather financial information: Obtain DIASORIN's financial statements, including balance sheets, income statements, and cash flow statements.
  • Determine DIASORIN's revenue streams: Identify DIASORIN's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
  • Analyze market data: Research DIASORIN's industry and market trends, including the size of the market, growth rate, and competition.
  • Establish DIASORIN's growth potential: Evaluate DIASORIN's management, business model, and growth potential.
  • Determine DIASORIN's financial performance: Analyze its financial statements to assess its historical performance and future potential.
  • Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
  • Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate DIASORIN's estimated value.
  • Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Note: This is a general outline, and different approaches and methods may be used depending on the type and size of the company being valued. We also recomment to seek professional assistance to ensure accuracy.

Complementary Tools for DIASORIN Stock analysis

When running DIASORIN's price analysis, check to measure DIASORIN's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy DIASORIN is operating at the current time. Most of DIASORIN's value examination focuses on studying past and present price action to predict the probability of DIASORIN's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move DIASORIN's price. Additionally, you may evaluate how the addition of DIASORIN to your portfolios can decrease your overall portfolio volatility.
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Commodity Directory
Find actively traded commodities issued by global exchanges
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital